What is he best known for?
The fields of study he is best known for:
His primary areas of study are Biochemistry, Escherichia coli, Penicillin binding proteins, Gene and Cell shape.
Biochemistry is closely attributed to Pseudomonas in his study.
The concepts of his Escherichia coli study are interwoven with issues in Bacterial growth, Tryptophan, Tryptophan transport, Enzyme and Indole test.
Kevin D. Young has researched Penicillin binding proteins in several fields, including Peptidoglycan and Mutant.
His Gene study deals with Molecular biology intersecting with Peptidylprolyl isomerase.
His Cell shape research integrates issues from Cell cycle and Cell biology.
His most cited work include:
- The Selective Value of Bacterial Shape (619 citations)
- Escherichia coli Mutants Lacking All Possible Combinations of Eight Penicillin Binding Proteins: Viability, Characteristics, and Implications for Peptidoglycan Synthesis (244 citations)
- Characterization of the desulfurization genes from Rhodococcus sp. strain IGTS8. (222 citations)
What are the main themes of his work throughout his whole career to date?
Kevin D. Young spends much of his time researching Escherichia coli, Biochemistry, Peptidoglycan, Penicillin binding proteins and Mutant.
His Escherichia coli research includes elements of Molecular biology, Peptide sequence and Inner membrane.
His study focuses on the intersection of Biochemistry and fields such as Biophysics with connections in the field of Lipid II.
His Peptidoglycan study combines topics in areas such as Cell division, Bacterial cell structure and Cell biology.
His research in Penicillin binding proteins intersects with topics in Endopeptidase, Cell membrane, Fusion protein and Binding site.
His Mutant research is multidisciplinary, relying on both Mutation, Cell sorting, Intracellular and Carboxypeptidase.
He most often published in these fields:
- Escherichia coli (57.78%)
- Biochemistry (57.78%)
- Peptidoglycan (42.22%)
What were the highlights of his more recent work (between 2010-2021)?
- Peptidoglycan (42.22%)
- Escherichia coli (57.78%)
- Biochemistry (57.78%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Peptidoglycan, Escherichia coli, Biochemistry, Cell wall and Mutant.
His Peptidoglycan study integrates concerns from other disciplines, such as Cell division, Penicillin binding proteins, Bacterial cell structure and Cell biology.
Kevin D. Young has included themes like Cell cycle and Cell shape in his Cell division study.
The Escherichia coli study combines topics in areas such as Cytoplasm and Enzyme.
Kevin D. Young is interested in Bacterial outer membrane, which is a field of Biochemistry.
His Cell wall research is multidisciplinary, incorporating perspectives in Periplasmic space, Cell envelope and Spheroplast.
Between 2010 and 2021, his most popular works were:
- What determines cell size (138 citations)
- Indole production by the tryptophanase TnaA in Escherichia coli is determined by the amount of exogenous tryptophan (116 citations)
- The Rcs stress response and accessory envelope proteins are required for de novo generation of cell shape in Escherichia coli (70 citations)
In his most recent research, the most cited papers focused on:
His primary areas of investigation include Biochemistry, Cell wall, Peptidoglycan, Escherichia coli and Cell biology.
His Biochemistry study frequently draws connections between adjacent fields such as Bacterial growth.
His Escherichia coli research focuses on Bacterial outer membrane in particular.
His Cell biology research includes themes of Peptidoglycan glycosyltransferase, Penicillin binding proteins and FtsZ, Cell division.
His study in FtsZ is interdisciplinary in nature, drawing from both Periplasmic space, Cell Cycle Protein and Spheroplast.
His biological study spans a wide range of topics, including Cell shape, Cell cycle and Cell type.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
